The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION (ACAID): REGULATION, BIOLOGICAL RELEVANCE, AND IMPLICATIONS FOR THERAPY
Abstract
Immune privilege was first explored in the late 1800s by van Dooremaal, and was then extended by Medawar in the mid 1900s to fit in with emerging concepts of transplantation immunology. Modern concepts and understanding of immune privilege come from subsequent studies produced by Medawar, Billingham, and Streilein. The exploitation of the model of anterior chamber immune deviation (ACAID) in mice has allowed us to look at both cellular and molecular mechanisms involved in the prevention of potentially damaging immune responses in such privileged sites. This review gives a historical perspective of the immune privilege research and provides up-to-date information of molecules, cells, and concepts newly recognized as contributing to tolerance induction induced in such specialized areas of the body. Evidence is given to support the idea that application of such information may lead to potential for therapeutic applications of ACAID mechanisms in prevention of progression of immune-inflammatory diseases in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“subretinally delivered vectors elicit a relatively reduced immune response akin to anterior chamber-associated immune deviation (ACAID).93,94”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [94]
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
CD1 Recognition by Mouse NK1 + T Lymphocytes
Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., & Brutkiewicz, R. R. (1995) · Science · doi:10.1126/science.7538697 · Cited by 914
Weiner, H. L. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.809 · Cited by 906
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
Porcelli, S., Yockey, C. E., Brenner, M. B., & Balk, S. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.1 · Cited by 756
Oral tolerance: immune mechanisms and treatment of autoimmune diseases
Weiner, H. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01053-0 · Cited by 731
Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view
Cserr, H. F., & Knopf, P. M. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90027-5 · Cited by 653
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., et al. (1998) · Nature · doi:10.1038/34419 · Cited by 646
Research works printed but not linked: 44
- van Dooremaal J.C., 1873, Akbrecg. Vab. Graefes Arch. Opthalomol., 19, 358
- P.B., 1945, London, 79, 157
- P.B., 1948, Pathol., 29, 58
- Streilein J.W., 1979, Masson et Cie, 174
- Asherson G.L., 1965, Immunology, 9, 205
- Niederkorn J., 1980, Invest. Opthalmol. Vis. Sci., 20, 355
- Whittum J.A., 1984, Invest. Opthalmol. Vis. Sci., 25, 1065
- McLeish W., 1989, Regional Immunol., 2, 236
- Niederkorn J.Y., 1990, Adv. Immunol., 48, 1999
- Mizuno K., 1989, Invest. Ophthalmol. Vis. Sci., 30, 1112
- Streilein J.W., 2001, Invest. Ophthalmol. Vis. Sci., 42, S523
- Jiang L.Q., 1991, Invest. Ophthalmol. Vis. Sci., 32, 224
- Jiang L.Q., 1993, Invest. Opthahalmol. Vis. Sci., 34, 3347
- Eichorn M., 1993, Invest. Ophthalmol. Vis. Sci., 34, 2926
- Kaiser C.J., 1985, Regional Immunol., 2, 42
- Taylor A.W., 1998, Invest. Opthahalmol. Vis. Sci., 39, 1372
- Miyamoto K.I., 1999, Invest. Ophthalmol. Vis. Sci., 40, S986
- Takeuchi M., 1999, Immunol., 98576
- Goslings R.O., 1998, Invest. Ophthalmol. Vis. Sci., 39, 989
- Cousins S.W., 1991, Invest. Ophthalmol. Vis. Sci., 32, 2201
- Biros D.J., 2001, Invest. Ophthalmol. Vis. Sci., 42, S929
- Knisely T.L., 1994, Invest. Opthalmol. Vis. Sci., 35, 3711
- Williamson S.P., 1989, Immunology, 67, 96
- H., 1989, The Journal of Immunology, 153, 1982
- Kezuka T., 2000, Immunology, 41, 1410
- Yao Y.F., 1997, Invest. Ophthalmol. Vis. Sci., 38, 534
- Kezuka T., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1803
- Kezuka T., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1410
- Waldrep J.C., 1984, Invest. Opthalmol. Vis. Sci., 25, 447
- Wilbanks G., 1990, Immunology, 71, 383
- Martin F., 2000, Immunol. Rev., 175, 70, 10.1111/j.1600-065X.2000.imr017515.x · doi:10.1111/j.1600-065x.2000.imr017515.x · Paper page
- Sonoda K.-H., 2001, Invest. Opthalmol. Vis. Sci., 42, S930
- Sonoda K.-H., 2001, Stein-Streilein. J. Immunol., 166, 42
- Faunce D.E., 2001, Invest. Opthalmol. Vis. Sci., 42, S930
- T., 1999, Cancer Res., 59, 5102
- Parker D.C., 1992, FASEB J., 131, 2777
- Wilbanks G.A., 1989, Regional Immunol., 2, 390
- Wilbanks G.A., 1990, Immunology, 71, 383
- 10.1146/annurev.iy.12.040194.004113 · doi:10.1146/annurev.iy.12.040194.004113 · Paper page
- Mosmann T.R., 1992, Sci., 664, 89
- Wilbanks G.A., 1990, Immunology, 71, 566
- Atherton S.S., 1987, Invest. Opthamol. Vis. Sci., 28, 859
- Rouse M.G., 1992, J. Immunol., 142, 3035
- Niederkorn J.Y., 1996, Invest. Ophthalmol. Vis. Sci., 37, 2700
Cited by
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
Marie, J. C., Letterio, J. J., Gavin, M., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042276 · Cited by 985
“Nevertheless, it will be of interest to experimentally test whether substantial amounts of TGF- 1 displayed by some immunoprivileged tissues and organs, like the ocular chamber of the eye, can facilitate maintenance, expansion, or de novo generation of antigen-specific T reg cells (27).”
BackgroundOcular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807
Self-citationCNS immune privilege: hiding in plain sight
Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D., & Ploix, C. C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00441.x · Cited by 795
“Within the CNS, Streilein and colleagues (112) were among the first to provide evidence that CNS antigens were not hidden from the immune system.”
BackgroundCurrent clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
“Unlike systemically delivered AAV, subretinally delivered vectors elicit a relatively reduced immune response akin to anterior chamber-associated immune deviation (ACAID).(93,94) However, SRI is a challenging technique, described as “almost a subspecialty unto itself.”
BackgroundA look at autoimmunity and inflammation in the eye
Caspi, R. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42440 · Cited by 482
“There, it induces the generation of antigen-specific CD4+ and CD8+ regulatory T cells through a complex mechanism involving B cells and NKT cells (64).”
BackgroundLin, H.-H., Faunce, D. E., Stacey, M., Terajewicz, A., Nakamura, T., Zhang-Hoover, J., Kerley, M., Mucenski, M. L., Gordon, S., & Stein-Streilein, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042307 · Cited by 385
“Although the gut/intestine is not considered to be an immune privileged site (27), an essential feature of the intestinal immune system is its ability to discriminate between harmful and harmless foreign proteins (44).”
BackgroundInfluentialSelf-citationActivation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis
Ma-Krupa, W., Jeon, M.-S., Spoerl, S., Tedder, T. F., Goronzy, J. J., & Weyand, C. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030850 · Cited by 283
“In that sense, the large arteries should be considered a territory desirable to be protected by immune privilege, comparable to the eyes or the testes (35, 36).”
BackgroundZhou, R., & Caspi, R. R. (2010) · F1000 Biology Reports · doi:10.3410/b2-3 · Cited by 259
“It involvesmigration from the eye to the spleen of F4/80 antigen-presenting cells that interact with invariant natural killer T cells and B cells and culminates in elicitation of systemic regulatory immunity through induction of CD4 afferent and CD8 efferent Treg cells (reviewed in [4,6]).”
BackgroundAmaro, A., Gangemi, R., Piaggio, F., Angelini, G., Barisione, G., Ferrini, S., & Pfeffer, U. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9663-3 · Cited by 241
“Also, the injection of foreign antigen into the anterior chamber activates suppressor Tcells, which inhibit the systemic immune response against the same antigen, a phenomenon defined as anterior chamberassociated immune deviation (ACAID) [293].”
BackgroundImmunophysiology and Pathology of Inflammation in the Testis and Epididymis
Hedger, M. P. (2011) · Journal of Andrology · doi:10.2164/jandrol.111.012989 · Cited by 237
“In general, Th2 cells and alternatively activated (M2) macrophages have been associated with immune privi-lege and tolerance in a number of systems (Cobbold and Waldmann, 1998; Stein-Streilein and Streilein, 2002; Martinez et al, 2008) .”
BackgroundTherapeutic potential of oral tolerance
Mayer, L., & Shao, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1370 · Cited by 212
Novel Strategies for Anterior Segment Ocular Drug Delivery
Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189
Regulatory T cells and organ transplantation
Waldmann, H. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.007 · Cited by 173
“ACAID is the best understood of such tissue-T-cell interfaces [42].”
BackgroundImmune privilege in corneal transplantation
Hori, J., Yamaguchi, T., Keino, H., Hamrah, P., & Maruyama, K. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.04.002 · Cited by 166
Immune Privilege and Eye-Derived T-Regulatory Cells
Keino, H., Horie, S., & Sugita, S. (2018) · Journal of Immunology Research · doi:10.1155/2018/1679197 · Cited by 163
“Both ocular resident mesenchymal cells and peripheral tolerance of ACAID actively contribute to the regulation of immune responses via the generation of Tregs.”
BackgroundInfluentialOcular autoimmunity: the price of privilege?
Caspi, R. R. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00439.x · Cited by 162
“A large body of experimental evidence supports the notion that immune privilege has an important role in directly and indirectly dampening inflammatory processes occurring in the eye (2, 18, 26, 32).”
BackgroundNew Insights into the Cell Biology of the Marginal Zone of the Spleen
Kraal, G., & Mebius, R. E. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)50005-1 · Cited by 168
“The majority of these tolerogenic responses do not lead to any involvement of the spleen (Samsom et al., 2005; Unger et al., 2003) , with the exception of immune responses that are generated in the eye (Camelo et al., 2005; Stein-Streilein and Streilein, 2002) .”
BackgroundLocke, S. A., McLaughlin, J., Dayanandan, S. D., & Marcogliese, D. J. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.08.012 · Cited by 155
“It is unlikely that parasites in these tissues are ‘‘hidden” from the host; rather, the immune response is subject to active, localised restraint (Stein-Streilein and Streilein, 2002).”
BackgroundImmune privilege induced by regulatory T cells in transplantation tolerance
Cobbold, S. P., Adams, E., Graça, L., Daley, S. R., Yates, S., Paterson, A. M., Robertson, N. J., Nolan, K. F., Fairchild, P. J., & Waldmann, H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00428.x · Cited by 135
“It has long been considered that certain organs, such as the anterior chamber of the eye, the brain, the testes, and the placenta, represent sites of relative immune privilege, such that the administration of foreign antigens into these sites can lead to a state of tolerance rather than immunization (1).”
BackgroundWest, E. L., Pearson, R. A., Barker, S. E., Luhmann, U. F. O., MacLaren, R. E., Barber, A. C., Durán, Y., Smith, A. J., Sowden, J. C., & Ali, R. R. (2010) · Stem Cells · doi:10.1002/stem.520 · Cited by 140
“These cells are produced in the spleen and suppress the host immune reactions to alloantigens present in the anterior chamber of the eye [8, 9].”
Backgroundde Kozak, Y., Andrieux, K., Villarroya, H., Klein, C., Thillaye‐Goldenberg, B., Naud, M., Garcia, E., & Couvreur, P. (2004) · European Journal of Immunology · doi:10.1002/eji.200425022 · Cited by 130
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130
Innate Immune Response in Retinal Homeostasis and Inflammatory Disorders
Murakami, Y., Ishikawa, K., Nakao, S., & Sonoda, K.-H. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100778 · Cited by 125
Regeneration, tissue injury and the immune response
Godwin, J. W., & Brockes, J. P. (2006) · Journal of Anatomy · doi:10.1111/j.1469-7580.2006.00626.x · Cited by 134
“This process generates antigen-specific regulatory T cells (CD4+ and CD8+) that inhibit the induction and expression of pro-inflammatory effector modalities (Stein-Streilein & Streilein, 2002).”
BackgroundA vision of cell death: Fas ligand and immune privilege 10 years later
Ferguson, T. A., & Griffith, T. S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00430.x · Cited by 127
“When the tumors were placed in the eye (where TGFb and immune-privileged mediators are abundant), no granulocytic infiltrate was observed, and the tumors grew.”
BackgroundInfluentialNakamura, T., Sonoda, K., Faunce, D. E., Gumperz, J. E., Yamamura, T., Miyake, S., & Stein‐Streilein, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1266 · Cited by 123
Self-citationDamaging Effects of Ultraviolet Radiation on the Cornea
Delic, N. C., Lyons, J. G., Girolamo, N. D., & Halliday, G. M. (2016) · Photochemistry and Photobiology · doi:10.1111/php.12686 · Cited by 120
“However, this hypothesis was challenged when Kaplan and Streilein (79) found the presence of hemagglutinating antibodies in serum from rats, 4 days after being immunized intracamerally with allogeneic lymphoid cells, concluding that antigens present in the anterior chamber can indeed elicit a systemic immune response…”
Corneal Allograft Rejection: Immunopathogenesis to Therapeutics
Hamrah, Y. Q. P. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s9-006 · Cited by 113
“The most notable contribution is that of anterior chamber-associated immune deviation (ACAID), an alloantigen-specific peripheral immune tolerance to antigens in the anterior chamber, capable of deviating the systemic cytotoxic immune response [52,53].”
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ghorani, E., Swanton, C., & Quezada, S. A. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.004 · Cited by 124
“…privilege include maintenance of self-reactive T cells in an ignorant state with limited access to antigenic stimulation, 25 diversion of effector T cells to hy-pofunctional 26 or suppressive states, 27 and promotion of apoptotic T cell death 28 with similar mechanisms operating at other sites.”
BackgroundThe dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis
Kerr, E. C., Copland, D. A., Dick, A. D., & Nicholson, L. B. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.001 · Cited by 109
“The eye has long been recognized as an immune privileged organ (Stein-Streilein and Streilein, 2002).”
Wiley, L. A., Burnight, E. R., Songstad, A. E., Drack, A. V., Mullins, R. F., Stone, E. M., & Tucker, B. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.10.002 · Cited by 122
Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate
Comstock, T. L., & DeCory, H. H. (2012) · International Journal of Inflammation · doi:10.1155/2012/789623 · Cited by 117
“Nevertheless, topical ophthalmic corticosteroids are associated with ADRs including elevations in IOP, cataract formation following extended use, delayed wound healing, and lower resistance to infection [1, 7].”
BackgroundA function for the macrophage F4/80 molecule in tolerance induction
VandenBerg, T., & Kraal, G. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.07.008 · Cited by 99
Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells
Caspi, R. R. (2008) · Immunologic Research · doi:10.1007/s12026-008-8031-3 · Cited by 94
“Immune privilege is a complex phenomenon that involves multiple components, starting with sequestration behind an efficient blood–retina barrier, through active local inhibition by soluble and surface-bound molecules that actively inhibit activation and function of adaptive and innate immune cells, and culminating in…”
BackgroundZhou, R., Horai, R., Silver, P. B., Mattapallil, M. J., Zárate-Bladés, C. R., Chong, W. P., Chen, J., Rigden, R. C., Villasmil, R., & Caspi, R. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102415 · Cited by 106
The eye: A window to the soul of the immune system
Perez, V. L., Saeed, A. M., Tan, Y. C. R. S., Urbieta, M., & Cruz‐Guilloty, F. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.011 · Cited by 93
Guedes, G., Tsai, J. C., & Loewen, N. A. (2011) · Current Aging Science · doi:10.2174/1874609811104020110 · Cited by 99
Banking on iPSC- Is it Doable and is it Worthwhile
Solomon, S., Pitossi, F. J., & Rao, M. S. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9574-4 · Cited by 90
“Proponents of such allogeneic therapy model have argued that immune suppression may not be required in many cases such as when cells are only required for a short time period or when cells themselves are not immunogenic or when cells are transplanted into immune privileged sites [11–13].”
BackgroundMicroRNA-145 Regulates Human Corneal Epithelial Differentiation
Lee, S. K.-W., Teng, Y., Wong, H.-K., Ng, T. K., Huang, L., Peng, L., Choy, K. W., Liu, Y., Zhang, M., Lam, D. S.-C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021249 · Cited by 87
“This can be associated with low vascularization, presence of Fas ligand, which is a target of aVb8 integrin, and TRAIL molecules and inhibitory substances in the aqueous humor [36].”
BackgroundUveal melanoma as a target for immune-therapy
Oliva, M., Rullan, A., & Piulats, J. M. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.05.04 · Cited by 81
“Furthermore this immune response inhibition is not limited to the eye, and by means of a process called anterior chamber-associated immune deviation (ACAID) active immune cells interact with the immune system to induce unusual suppression of the systemic immune response when an antigen is detected in the anterior cham…”
BackgroundInfluentialZinc Nutrition and Inflammation in the Aging Retina
Gilbert, R. M., Pető, T., Lengyel, I., & Emri, E. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801049 · Cited by 88
An Immunologically Privileged Retinal Antigen Elicits Tolerance
Avichezer, D., Grajewski, R. S., Chan, C., Mattapallil, M. J., Silver, P. B., Raber, J., Liou, G. I., Wiggert, B. O., Lewis, G. M., Donoso, L. A., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030413 · Cited by 78
“It is still unresolved whether the ACAID phenomenon, which is well studied with relation to injected proteins (5, 6), is elicited by native retinal antigens residing in the intact eye.”
BackgroundRoelofs-Haarhuis, K., Wu, X., & Gleichmann, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1043 · Cited by 78
Huang, Y., He, J., Liang, H., Hu, K., Jiang, S., Yang, L., Mei, S., Zhu, X. M., Yu, J. H., Kijlstra, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01713 · Cited by 77
Stem cells for investigation and treatment of inherited retinal disease
Tucker, B. A., Mullins, R. F., & Stone, E. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu124 · Cited by 74
“the anterior chamber-associated immune deviation (25,26)].”
Matching for Human Leukocyte Antigens (HLA) in corneal transplantation – To do or not to do
van Essen, T. H., Roelen, D. L., Williams, K. A., & Jager, M. J. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.01.001 · Cited by 65
“Although they can exacerbate a rejection, alloantibodies are not believed to be by themselves capable of acutely rejecting corneal grafts, most likely due to the lack of blood vessels in low risk grafts (George and Larkin, 2004; Goslings et al., 1998; Stein-Streilein and Streilein, 2002).”
BackgroundInvariant NKT Cells and Tolerance
Nowak, M. A., & Stein‐Streilein, J. (2007) · International Reviews of Immunology · doi:10.1080/08830180601070195 · Cited by 67
Self-citationImmune Privilege: The Microbiome and Uveitis
Mölzer, C., Heissigerová, J., Wilson, H. M., Kuffová, L., & Forrester, J. V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608377 · Cited by 73
Limited Peripheral T Cell Anergy Predisposes to Retinal Autoimmunity
Lambe, T., Leung, J. C. H., Ferry, H., Bouriez‐Jones, T., Makinen, K., Crockford, T. L., Jiang, H., Nickerson, J. M., Peltonen, L., Forrester, J. V., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4276 · Cited by 59
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
Rossi, E., Schinzari, G., Zizzari, I. G., Maiorano, B. A., Pagliara, M. M., Sammarco, M. G., Fiorentino, V., Petrone, G., Cassano, A., Rindi, G., et al. (2019) · Cancers · doi:10.3390/cancers11081055 · Cited by 58
“When antigens enter the eye, a unique mechanism of immune privilege is involved: it is termed “anterior chamber-associated immune deviation” (ACAID), an immunomodulatory phenomenon involving the eye, but also the thymus, spleen, and sympathetic nervous system [41].”
BackgroundMurine CD8+ regulatory T lymphocytes: The new era
Pomié, C., Marcq, I., & van Meerwijk, J. P. M. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.288 · Cited by 70
Complement regulation in the eye: implications for age-related macular degeneration
Wilke, G. A., & Apte, R. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178296 · Cited by 55
“This immune-sup-pression phenomenon is called “anterior chamber–associated immune deviation” (ACAID) (28).”
Local Activation of Dendritic Cells Alters the Pathogenesis of Autoimmune Disease in the Retina
Heuss, N. D., Lehmann, U., Norbury, C. C., McPherson, S. W., & Gregerson, D. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101621 · Cited by 53
“An important mechanism of ocular immune privilege, that is, immune deviation, was subsequently elucidated by Streilein (14).”
BackgroundRegulation of epigenetic homeostasis in uveal melanoma and retinoblastoma
Chai, P., Jia, R., Li, Y., Zhou, C., Gu, X., Yang, L., Shi, H., Tian, H., Lin, H., Yu, J., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101030 · Cited by 56
Involvement of B cells in non‐infectious uveitis
Smith, J. R., Stempel, A. J., Bharadwaj, A. S., & Appukuttan, B. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.2 · Cited by 52
Chen, J., & Caspi, R. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8938-6_15 · Cited by 55
Herpetic eye disease: immunopathogenesis and therapeutic measures
Kaistha, S. D., Banerjee, K., Biswas, P. S., & Rouse, B. T. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404007604 · Cited by 51
Keino, H., Masli, S., Sasaki, S., Streilein, J. W., & Stein‐Streilein, J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1454 · Cited by 50
“A considerable body of experimental evidence indicates that ACAID is triggered by indigenous, intraocular bone marrow–derived antigen-presenting cells (APCs) that capture antigen within the AC and deliver an antigen-specific, ACAID-inducing signal via the blood directly to the spleen.(3,4) ACAID mice express two funct…”
Self-citationNanosuspensions in ophthalmology: Overcoming challenges and enhancing drug delivery for eye diseases
Fathi‐karkan, S., Ramsheh, N. A., Arkaban, H., Narooie-Noori, F., Sargazi, S., Mirinejad, S., Roostaee, M., Sargazi, S., Barani, M., Shadman, S. M., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124226 · Cited by 56
An eye’s view of T regulatory cells
Stein‐Streilein, J., & Taylor, A. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606383 · Cited by 48
“lines the posterior surface of the iris, the ciliary body, and neural retina and thus, partially surrounds the privileged sites [41] of the anterior chamber [31], the vitreous cavity [88], and the subretinal space [89, 90], respectively.”
BackgroundSelf-citationMacrophage-Mediated Tissue Vascularization: Similarities and Differences Between Cornea and Skin
Hadrian, K., Willenborg, S., Bock, F., Cursiefen, C., Eming, S. A., & Hos, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667830 · Cited by 50
Vendomèle, J., Khebizi, Q., & Fisson, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01686 · Cited by 44
Hori, J., Kunishige, T., & Nakano, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113962 · Cited by 47
“ACAID is a form of systemic tolerance to antigens placed in the anterior chamber of the eye [22,23].”
BackgroundFarooq, S. M., & Ashour, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048635 · Cited by 40
“These ocular APCs interact with marginal zone B cells, cd T cells, and NK T-cells in the spleen in order to induce the differentiation of CD4 afferent Tregs and CD8 efferent Tregs [7,10,12,13].”
BackgroundYang, J., Walia, A., Huang, Y.-H., Han, K., Rosenblatt, M. I., Azar, D. T., & Chang, J. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.12.004 · Cited by 38
Derks, R. A., Jankowska−Gan, E., Xu, Q., & Burlingham, W. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3443 · Cited by 38
Innate Immunity and Resistance to Tolerogenesis in Allotransplantation
Bénichou, G., Tonsho, M., Tocco, G., Nadazdin, O., & Madsen, J. C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00073 · Cited by 42
“, 2001) and immune privilege (Stein-Streilein and Streilein, 2002; Streilein et al., 2002; Masli et al., 2006) presumably via T cell anergy (Fu et al.”
BackgroundRetinal Laser Burn-Induced Neuropathy Leads to Substance P-Dependent Loss of Ocular Immune Privilege
Lucas, K. G., Karamichos, D., Mathew, R., Zieske, J. D., & Stein‐Streilein, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103264 · Cited by 37
“mechanisms contribute to immune homeostasis and control inflammation in the eye and define ocular immune privilege as we know it (26, 27).”
BackgroundSelf-citationGene transfer to the outflow tract
Dang, Y., Loewen, R. T., Parikh, H., Roy, P., & Loewen, N. A. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.04.023 · Cited by 36
“The ability of the TM and Schlemm’s canal to present antigens and induce tolerance (anterior chamber associated immune deviation, ACAID, (Stein-Streilein and Streilein, 2002), may work in favor of gene transfer to the outflow tract by reducing immunity against vector and transgene.”
BackgroundRoelofs-Haarhuis, K., Wu, X., Nowak, M. A., Fang, M., Artik, S., & Gleichmann, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2863 · Cited by 36
T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis
Napier, R. J., Lee, E. J., Davey, M. P., Vance, E. E., Furtado, J. M., Snow, P., Samson, K. A., Lashley, S. J., Brown, B. R., Horai, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18961-0 · Cited by 34
Silver, P. B., Agarwal, R. K., Su, S.-B., Suffia, I., Grajewski, R. S., Luger, D., Chan, C., Mahdi, R. M., Nickerson, J. M., & Caspi, R. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5146 · Cited by 37
The role of pro-resolving lipid mediators in ocular diseases
Wei, J., & Gronert, K. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.006 · Cited by 32
“…from the past few decades have established immune privilege as active surveillance where immunosuppression and regulatory cells are actively deployed to avert full-fledged innate or adaptive immune responses (Stein-Streilein and Streilein, 2002; de Andrade et al., 2016).”
BackgroundEmerging roles of transforming growth factor β signaling in wet age-related macular degeneration
Wang, K., Li, H., Sun, R., Liu, C., Luo, Y., Fu, S., & Ying, Y. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy145 · Cited by 33
“We predict that when TGF-β declines below a threshold, its inhibitory effect on immune cells will be disrupted, the ACAID effect will be greatly reduced, and the immune reactivity will increase.”
BackgroundSchrittenlocher, S., Grass, C., Dietlein, T. S., Lappas, A., Matthaei, M., Cursiefen, C., & Bachmann, B. O. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05506-4 · Cited by 32
Mechanisms of Maternal Immune Tolerance During Pregnancy
John, E., Jorge, M., Jonathan, W., Ea, V. L., & Smith, R. (2012) · InTech eBooks · doi:10.5772/33541 · Cited by 32
“The concept of immune-privileged sites has been recognized by immunologists for nearly 135 years, since the Dutch ophthalmologist Van Dooremaal observed prolonged survival of a mouse skin graft placed into the anterior chamber of a dog’s eye (reviewed in (Stein-Streilein and Streilein, 2002)).”
Regional Immunity and Immune Privilege
Kaplan, H. J., & Niederkorn, J. Y. (2007) · KARGER eBooks · doi:10.1159/000099237 · Cited by 35
Non‐invasive in vivo imaging of pancreatic β‐cell function and survival – a perspective
Leibiger, I. B., Caicedo, A., & Berggren, P. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02301.x · Cited by 29
“…privilege properties, the simple procedure, the easy non-invasive monitoring of the graft, the possibility of delivering local immunosuppression and the potential for systemic tolerization through anterior chamber-associated immune deviation as discussed in Stein-Streilein & Streilein (2002).”
BackgroundCone, R. E., & Pais, R. (2009) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s2858 · Cited by 40
The good, the bad and the ugly – APCs of the eye
Novak, N., Siepmann, K., Zierhut, M., & Bieber, T. R. M. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.009 · Cited by 31
An anatomical view on macrophages in tolerance
Wermeling, F., Karlsson, M. C. I., & McGaha, T. L. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.03.004 · Cited by 30
Linear '2–0–1' lymphocyte development: hypotheses on cellular bases for immunity
PERUSSIA, B., & Loza, M. J. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00080-2 · Cited by 36
Esfandiari, H., Taubenslag, K. J., Shah, P., Goyal, S., Weiner, A. J., Severson, M. L., Weiner, A., Grover, D. S., Bussel, I. I., & Loewen, N. A. (2019) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2018.12.011 · Cited by 29
A Comprehensive Understanding of Choroidal Metastasis from Lung Cancer
Qu, Z., Liu, J., Zhu, L., & Zhou, Q. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s315532 · Cited by 30
“When antigens enter the eye, a unique mechanism of immune privilege known as “anterior chamber-associated immune deviation” (ACAID) is involved in the immunomodulatory phenomenon.(94) Second, a physical barrier known as the blood-retinal barrier (BRB) that forms tight junctions between endothelial cells, and the retin…”
BackgroundPresence and phenotype of dendritic cells in uveal melanoma
Polak, M. E., Borthwick, N., Johnson, P., Hungerford, J. L., Higgins, B., Palma, S. D., Jager, M. J., & Cree, I. A. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.110908 · Cited by 29
Invariant NKT Cells as Initiators, Licensors, and Facilitators of the Adaptive Immune Response
Stein‐Streilein, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031946 · Cited by 29
“The development of CD8 Tr cells in this model has now been clearly shown to depend on a distinct population of iNKT cells that make IL-10 (20), TGF (21), but not IL-4 or IL-13 (unpublished data).”
BackgroundSelf-citationCAR T reg cells mediate linked suppression and infectious tolerance in islet transplantation in mice
Wardell, C. M., Fung, V. C. W., Chen, E., Haque, M., Tan, D. F. H., Leca, M., Gillies, J. K., Spanier, J. A., Mojibian, M., Fife, B. T., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adp6519 · Cited by 38
Hsu, S.-M., Mathew, R., Taylor, A. W., & Stein‐Streilein, J. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12243 · Cited by 29
Self-citationTherapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye
Gilger, B. C., & Hirsch, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073465 · Cited by 25
“In addition, the eye has an active immune-suppressive mechanism, called the anterior chamber-associated immune deviation (ACAID), which suppresses the adaptive immune response to antigens presented in the eye [1].”
BackgroundInfluentialVitamin A, systemic T-cells, and the eye: Focus on degenerative retinal disease
Thirunavukarasu, A. J., Ross, A. C., & Gilbert, R. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.914457 · Cited by 31
“Ocular immune privilege is a complex phenomenon that involves multiple components, starting with sequestration behind an efficient blood–retina barrier, through active local inhibition by soluble and surface-bound molecules that actively inhibit activation and function of adaptive and innate immune cells, and culminat…”
BackgroundChen, X., Liu, L., Yang, P., Wu, C. Y., Jin, H., Lin, X., Li, B., Zhou, H., Huang, X., & Zhu, L. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.08.006 · Cited by 23
Gurnani, B., Kaur, K., Lalgudi, V. G., & Tripathy, K. (2023) · Clinical ophthalmology · doi:10.2147/opth.s398418 · Cited by 22
“Clinical Presentation of Descemet Membrane Endothelial Keratoplasty Rejection The clinical presentation of immune reaction or rejection in DMEK could vary a lot, ranging from a frank Khodadoust line(49) with corneal edema, keratic precipitates (KPs), and anterior chamber (AC) inflammation to just subtle subclinical AC…”
BackgroundInfluentialArginine depletion as a mechanism for the immune privilege of corneal allografts
Fu, H., Khan, A. H., Coe, D., Zaher, S. S., Chai, J., Kropf, P., Müller, I., Larkin, F., & George, A. J. T. (2011) · European Journal of Immunology · doi:10.1002/eji.201141683 · Cited by 22
Treacy, O., Fahy, G., Ritter, T., & O’Flynn, L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3139-2_13 · Cited by 22
New Insights Into Immunological Therapy for Retinal Disorders
Takeda, A., Yanai, R., Murakami, Y., Arima, M., & Sonoda, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01431 · Cited by 23
Dose dependence of oral tolerance to nickel
Wu, X., Roelofs-Haarhuis, K., Zhang, J., Nowak, M., Layland, L. E., Jermann, E., & Gleichmann, E. (2007) · International Immunology · doi:10.1093/intimm/dxm066 · Cited by 22
3D cell-laden polymers to release bioactive products in the eye
Orive, G., Santos‐Vizcaíno, E., Pedraz, J. L., Hernández, R. M., Ramirez, J. E. V., Dolatshahi‐Pirouz, A., Khademhosseini, A., Peppas, N. A., & Emerich, D. F. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.10.002 · Cited by 22
Pathophysiological Aspects of Ocular Toxoplasmosis: Host-parasite Interactions
Kalogeropoulos, D., Kalogeropoulos, C. D., Sakkas, H., Mohammed, B., Vartholomatos, G., Malamos, K., Sreekantam, S., Kanavaros, P., & de‐la‐Torre, A. (2021) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2021.1922706 · Cited by 22
Incidence and Risk Factors for Chronic Uveitis following Cataract Surgery
Patel, C., Kim, S. J., Chomsky, A. S., & Saboori, M. (2013) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2012.752013 · Cited by 20
Sequential Bilateral Corneal Transplantation and Graft Survival
Steger, B., Curnow, E., Cheeseman, R., Romano, V., Kaye, A. E., Jones, M. A., & Kaye, S. B. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.07.019 · Cited by 20
“The cornea differs from other tissues or organs in that it is a privileged site for transplantation owing to the absence of blood and lymphatic vessels, relative paucity of mature antigen-presenting cells, blood-eye barrier, and immunomodulatory factors within the eye.(2) Despite this, corneal graft failure is signifi…”
Background
Metadata
- Authors
- STEIN-STREILEIN, J., & STREILEIN, J. W.
- Affiliations
- Harvard University (US)
- Venue
- International Reviews of Immunology
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 21
- Issue
- 2-3
- Pages
- 123-152
- ISSN
- 0883-0185 (ISSN-L)
- 1563-5244
- OpenAlex
- W1966161103
- Cited by
- 218
- References
- 132
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 7 · 2012: 11
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Reviews of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- anterior chamber-associated immune deviation, immune privilege, tolerance induction, ocular immunology, transplantation immunology
- MeSH terms
- Animals, Anterior Chamber, Antigen-Presenting Cells, Eye Diseases, Graft vs Host Disease, Humans, Immune Tolerance, Killer Cells, Natural, Ovalbumin, T-Lymphocytes, Transplantation Immunology, Th1 Cells, Th2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.